Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to improving ...

Learn how HPV transmitted through oral sex can lead to throat cancer and discover the essential prevention strategies that ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

According to a statement issued on Monday by the Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, the ...

Preliminary results from the AACR 2025 Annual Meeting reveal encouraging clinical responses to the investigational oral agent ...

Scientists are learning more about the association between dietary intake and cancer. This connection is becoming ...

Co., LTD. received IND clearance from the FDA to initiate Phase 1 clinical trial in the United States for its NTS071, a novel small molecule allosteric reactivator targeting p53 Y220C mutation. NTS071 ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The Massachusetts biotech will focus its efforts and resources into cemsidomide, an oral drug candidate being trialed for multiple myeloma and non-Hodgkin lymphoma.

The initial POC results, presented April 26, 2025 at the Annual ELITE PED-GI Congress, show crofelemer reduced the required total parenteral nutrition (TPN) and/or supplementary intravenous fluids, ...

An investigational viral immunotherapy extended survival compared with standard care for patients with advanced non-small cell lung cancer who had inadequate response to immune checkpoint inhibitor ...

MSM is an anti-inflammatory dietary supplement sometimes used to reduce pain, improve skin health, relieve allergies, and ...